Rimsys Announces Rimsys AI. Smarter, Faster, and Built for Medtech!

Webinars

The Impact of MDR transition period extensions

Replay

Listen to a discussion of the recent extension to the MDR transition periods. It is important to understand what this means - and doesn't mean - for medtech companies marketing medical devices in the EU. Learn why this extension does not mean MDR certification should be delayed! Our panelists will include Rimsys experts - James Gianoutsos, founder and CEO; Bruce McKean, Director of Regulatory; and Adam Price, Director of Product for Post-Market.

Get the webinar

Get the webinar

Here's your video, enjoy!
Check out these additional resources
5 ways a RIM system can accelerate time-to-market for MedTech companies
5 ways a RIM system can accelerate time-to-market for MedTech companies
Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Learn why UDI is relevant to regulatory affairs and how Rimsys can help medtech RA teams manage the growing complexities associated with UDI data.
Learn why UDI is relevant to regulatory affairs and how Rimsys can help medtech RA teams manage the growing complexities associated with UDI data.
Oops! Something went wrong while submitting the form